New class of small molecule drug, SI-2, has potential for improving cancer treatment

Cancer cells communicate with their environment through cell molecules that pass on signals to the inside of the cell. SI-2 is a potent small-molecule inhibitor to drug the undruggable steroid receptor coactivator-3.